Curexo

060280 · KOSDAQ · Consumer Discretionary · SMALL CAP

A new supply contract.

Curexo disclosed a supply contract with Biorad Medisys Pvt.

Supply contract(Supply contract signed)· FILED 2026-05-20· RCEPT 20260520900257

US$5.64MContract value
11.4%vs. recent revenue
Dec 2026Throughfrom May 2026

Converted at 1 USD ≈ ₩1,499.77 (filing-date rate, 2026-05-20 close)

What happened

Curexo disclosed a supply contract with Biorad Medisys Pvt. Ltd., worth US$5.64M, about 11.4% of its recent annual revenue, running through Dec 2026.

For context, this single contract equals about 11.4% of the company's most recent annual revenue.

CounterpartyBiorad Medisys Pvt. Ltd.
Contract valueUS$5.64M
vs. recent revenue11.4%
ThroughDec 2026 (from May 2026)
Filed2026-05-20, Supply contract signed
SourceDART rcept 20260520900257 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-05-20 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.